Kalos Therapeutics

About:

Kalos Therapeutics develops atrial natriuretic peptides for the treatment of cancer.

Website: https://kalostherapeutics.com

Twitter/X: kalosinfo

Description:

Kalos Therapeutics is an emerging biomedical company with the exclusive patent to develop the ANP (atrial natriuretic peptide) family of peptides as a new mechanism for the treatment of cancer. Kalos is aggressively targeting diseases caused by an abnormally high growth rate of cells (hyperproliferation). Kalos is pioneering an approach to cancer treatment by developing peptides made primarily in the heart as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small-molecule compounds.